Compare JAZZ & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | TTC |
|---|---|---|
| Founded | 2003 | 1914 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Tools/Hardware |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 9.3B |
| IPO Year | 2007 | 1994 |
| Metric | JAZZ | TTC |
|---|---|---|
| Price | $239.49 | $90.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | ★ $217.57 | $104.00 |
| AVG Volume (30 Days) | ★ 843.6K | 576.5K |
| Earning Date | 05-05-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.43 | 0.69 |
| Revenue | $1,618,693,000.00 | ★ $2,618,650,000.00 |
| Revenue This Year | $6.22 | $6.13 |
| Revenue Next Year | $7.68 | $4.45 |
| P/E Ratio | ★ $54.00 | $129.90 |
| Revenue Growth | N/A | ★ 4.53 |
| 52 Week Low | $105.00 | $67.45 |
| 52 Week High | $242.18 | $105.19 |
| Indicator | JAZZ | TTC |
|---|---|---|
| Relative Strength Index (RSI) | 76.38 | 42.51 |
| Support Level | $128.87 | $77.96 |
| Resistance Level | N/A | $97.32 |
| Average True Range (ATR) | 6.06 | 2.38 |
| MACD | 0.92 | -0.33 |
| Stochastic Oscillator | 89.49 | 36.54 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.